Is the gefitinib plus trastuzumab combination feasible in breast cancer patients?

Normanno, N; Campiglio, M; Perrone, F; De Luca, A; Menard, S

Normanno, N; Campiglio, M; Perrone, F; De Luca, A; Menard, S.

Ann Oncol ; 16(10): 1709, 2005 Oct.

Article in En | MEDLINE | ID: mdl-16150806

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Gefitinib; Humans; Patient Selection; Quinazolines/administration & dosage; Reproducibility of Results; Trastuzumab; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Female / Humans Language: En Journal: Ann Oncol Year: 2005 Document type: Article

Search on Google

XML

PubMed Links